代谢组学
蛋白质组学
基因组学
计算生物学
生物
组学
生物信息学
鉴定(生物学)
睾酮(贴片)
生物医学
生理学
医学
内分泌学
基因组
遗传学
基因
植物
作者
Giuseppe Grande,Andrea Graziani,Luca De Toni,Andrea Garolla,Domenico Milardi,Alberto Ferlin
出处
期刊:Life
[Multidisciplinary Digital Publishing Institute]
日期:2023-09-01
卷期号:13 (9): 1854-1854
被引量:1
摘要
Although precision medicine took its first steps from genomic medicine, it has gone far beyond genomics, considering the full complexity of cellular physiology. Therefore, the present time can be considered as the “post-genomic era”. In detail, proteomics captures the overall protein profile of an analyzed sample, whilst metabolomics has the purpose of studying the molecular aspects of a known medical condition through the measurement of metabolites with low molecular weight in biological specimens. In this review, the role of post-genomic platforms, namely proteomics and metabolomics, is evaluated with a specific interest in their application for the identification of novel biomarkers in male hypogonadism and in the identification of new perspectives of knowledge on the pathophysiological function of testosterone. Post-genomic platforms, including MS-based proteomics and metabolomics based on ultra-high-performance liquid chromatography-HRMS, have been applied to find solutions to clinical questions related to the diagnosis and treatment of male hypogonadism. In detail, seminal proteomics helped us in identifying novel non-invasive markers of androgen activity to be translated into clinical practice, sperm proteomics revealed the role of testosterone in spermatogenesis, while serum metabolomics helped identify the different metabolic pathways associated with testosterone deficiency and replacement treatment, both in patients with insulin sensitivity and patients with insulin resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI